Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Castor oil for intestinal permeability in healthy participants
NCT06033222Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2024
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (4 arms), sponsored by Mayo Clinic. Primary endpoint: Change in urinary excretion of 13C-mannitol. Started Jan 2024; status: completed.
Beyond the preview
Go deeper on NCT06033222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06033222.